Unibest

Pharmaceutical intermediates

Rilzabrutinib Intermediates

3 pharmaceutical intermediates for Rilzabrutinib. Indication: Idiopathic thrombocytopenic purpura.

提交项目All intermediates

About Rilzabrutinib

Originator
Principia Biopharma Inc
Indication
Idiopathic thrombocytopenic purpura
DS/DP
09/06/2033

Available intermediates

3 intermediates currently listed for Rilzabrutinib. Request specifications, documentation or a quotation for any item below.

Rilzabrutinib intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(2-fluoro-4-phenoxyphenyl)boronic acid1414356-30-1//
3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine151266-23-8//
Benzyl 4-(oxetan-3-yl)piperazine-1-carboxylate1254115-22-4//

Other programs under R

Ramelteon RegorafenibRelugolixRemdesivir RemibrutinibRepotrectinibResmetiromRevumenib

Building toward Rilzabrutinib?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →